Seel, a couple of posters more in tune than I have recently expressed lots of confidence that the Ph1 trial for Kevetrin has pretty much been decided as to a positive result for safety.

What is your current opinion as to the likelihood that Kevetrin will make it to a pretty hefty MTD, or at least one higher than the 100-200 dosage rate where the pre clinical testing showed high efficacy?

Don't wreck my weekend and say you see no lesser risk now for Ph1 than when the trial started.  LOL.